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Abstract
Background: The demand for inpatient medical services increases during influenza season. A scoring system capable of
identifying influenza patients at low risk death or ICU admission could help clinicians make hospital admission decisions.
Methods: Hospitalized patients with laboratory confirmed influenza were identified over 3 influenza seasons at 25 Ontario
hospitals. Each patient was assigned a score for 6 pneumonia severity and 2 sepsis scores using the first data available
following their registration in the emergency room. In-hospital mortality and ICU admission were the outcomes. Score
performance was assessed using the area under the receiver operating characteristic curve (AUC) and the sensitivity and
specificity for identifying low risk patients (risk of outcome ,5%).
Results: The cohort consisted of 607 adult patients. Mean age was 76 years, 12% of patients died (71/607) and 9% required
ICU care (55/607). None of the scores examined demonstrated good discriminatory ability (AUC$0.80). The Pneumonia
Severity Index (AUC 0.78, 95% CI 0.72–0.83) and the Mortality in Emergency Department Sepsis score (AUC 0.77, 95% 0.71–
0.83) demonstrated fair predictive ability (AUC$0.70) for in-hospital mortality. The best predictor of ICU admission was
SMART-COP (AUC 0.73, 95% CI 0.67–0.79). All other scores were poor predictors (AUC ,0.70) of either outcome. If patients
classified as low risk for in-hospital mortality using the PSI were discharged, 35% of admissions would have been avoided.
Conclusions: None of the scores studied were good predictors of in-hospital mortality or ICU admission. The PSI and MEDS
score were fair predictors of death and if these results are validated, their use could reduce influenza admission rates
significantly.
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Introduction
Seasonal influenza results in over 50,000 deaths and 500,000
hospitalizations per year in the US alone [1,2]. Emergency
departments (ER) and inpatient medical services often operate
near maximum capacity during a moderately severe influenza
season [3]. The current H1N1 influenza pandemic is further
overloading healthcare systems as it spreads globally though
populations with minimal immunity to this virus.
Thus, in a busy influenza season or during a pandemic,
clinicians need to be able to rapidly assess large numbers of
patients with influenza-like illness (ILI) and identify those patients
that require inpatient care. The inappropriate admission of low
risk patients and the failure to admit high risk patients could lead
to widespread inefficiency within the healthcare system, and poor
outcomes for some patients.
An influenza severity score designed for use at the time that
admission decisions are made and capable of discriminating
between patients at high and low risk of severe disease and death
would be a valuable tool that could be used to develop clinical
pathways or decision support tools for use during influenza season
or during a pandemic, similar to those used for community
acquired pneumonia. Pneumonia severity scores such as the
Pneumonia Severity Index (PSI) [1,4] and the CURB-65 score
[5,6] have already been developed and are widely used to support
admission decisions for patients with community-acquired pneu-
monia (CAP). The CURB-65, the SOFA score, the Simple Triage
Scoring System (STSS) and the Pandemic Medical Early Warning
Score (PMEWS) have all been recommended for use during a
pandemic [3,7–11]. Unfortunately, none of these scores have been
evaluated using patients with influenza. To address this issue, we
assessed the performance of 13 pneumonia severity and acute
PLoS ONE | www.plosone.org 1 March 2010 | Volume 5 | Issue 3 | e9563physiology scores in a population of patients hospitalized with
influenza.
Methods
Ethics
Patients were identified by the microbiology laboratories at
all participating hospitals. Identified patients were approached
and written informed consent was obtained for inclusion in the
study and for chart review. Ethics approval for this study was
obtained from the research ethics boards of all participating
hospitals.
Setting and Study Population
This study was conducted by the Toronto Invasive Bacterial
Disease Network (TIBDN). TIBDN is a network of 25 hospitals
that conduct population-based surveillance for infectious diseases
in the Metropolitan Toronto and Peel Region, Ontario (popula-
tion 3.7 million). Since January 1, 2005 TIBDN hospitals have
been conducting active surveillance for patients admitted to
hospital with laboratory confirmed influenza. Details of the
surveillance methodology have been previously published [12].
We included in our cohort all adult (age$15 years) patients
admitted to a TIBDN hospital because of disease associated with
laboratory confirmed influenza during the 2005, 2006 or 2007
influenza season (January 2005 to April 2007). Patients were
considered to have laboratory confirmed influenza if any specimen
tested positive for influenza A or B by enzyme immunoassay, viral
culture or PCR [12].
Prognostic Scoring Systems
Scoring systems with potential usefulness in evaluating patients
with seasonal or pandemic influenza at the time of initial ER
assessment were identified through a MEDLINE search and
expert consultation (Table 1). Scores were considered if they
were designed for use at the time of ER assessment and/or
admission, were derived or validated in a cohort of patients with
influenza, pneumonia or sepsis, and were intended to predict
relevant outcomes (i.e. death, mechanical ventilation, ICU
admission).
Study Outcomes
The primary outcome for this study was in-hospital mortality.
The secondary outcome was admission to ICU.
Data Collection
Trained data abstractors used a standardized data collection
form to collect information on patient outcomes and all of the
demographic, clinical, laboratory and radiographic data required
to calculate each score. Only records obtained within 24 hours of
registration in the ER were included, and if .1 result was
obtained, the first recorded value was used to calculate the score.
Missing data was assumed to be normal. Data were entered in
duplicate, cleaned and analyzed in SAS (SAS version 9.0, SAS
Institute, Cary NC).
Statistical Methods
All prognostic scores were calculated for each patient using the
first data available after their arrival in the ER. The accuracy of
each score in predicting outcome was evaluated using measures of
discrimination (how well each score discriminates between patients
that do or do not progress to the outcome) and calibration
(whether the probabilities predicted by the score are, on average,
close to the observed outcomes) [13].
Discrimination was assessed by plotting the receiver operating
characteristic (ROC) curveand calculating the area under theROC
curve (AUC) [14,15]. The AUC is a standard method of measuring
and comparing the discrimination of multiple predictive models.
AUC values were ‘ranked’ as excellent (AUC$0.90), good
(AUC$0.80 and ,0.90), fair (AUC$0.70 and ,0.80) and poor
(,0.70). Confidence intervals around the AUC were calculated
using bootstrap re-sampling methods with 1000 repetitions [16].
Additionally, the sensitivity and specificity of each score were
calculated by using as a cutoff the value of each score that separated
patients with a predicted outcome risk of ,5% from those at higher
risk.
Calibration was assessed graphically using quintile plots of
observed versus expected outcome and statistically using the
Hosmer-Lemeshow C statistic [17]. The Hosmer-Lemeshow C
statistic compares observed vs. expected outcome within deciles of
the expected outcome. A statistically significant result suggests a
lack of calibration.
For all analyses, predictor variables with missing data were
assumed to be normal. To validate this approach, we compared
outcomes between patients with and without missing data and
repeated the analysis using multiple imputation to impute missing
values for all variables [18].
Results
Missing Data
Outcome data were complete. Data on predictor variables were
nearly complete (,4% missing) for all variables except arterial
blood gases, albumin and blood urea nitrogen which were missing
in 70%, 68% and 11% of cases. For these variables, the case
fatality rate was the same or lower in patients with missing data
compared to patients with documented results, supporting our
assumption that missing variables were likely within the normal
range [data not shown].
Cohort Description
We identified 617 hospitalized adult patients with laboratory
confirmed influenza over 3 influenza seasons. Of these, 10 were
not included either due to lack of informed consent (n=5) or lack
of access to their medical records (n=5). Therefore, 607 patients
(98%) were included. The median (IQR) age was 76 years (64
years to 83 years), 49% of cases were female and .80% of patients
had one or more chronic medical illness. Patients were admitted
Table 1. Prognostic Scoring Systems.
Scoring System
Patient
Population Abbreviation
CURB-65 [21] CAP CURB65
Mortality in Emergency Department Sepsis [20] Sepsis MEDS
Nursing Home Acquired Pneumonia in the
Elderly [22]
CAP NHAP
Pandemic Medical Early Warning Score [7] CAP PMEWS
Pneumonia Severity Index [23] CAP PSI
Severity Score for the Elderly with Community
Acquired Pneumonia [24]
CAP CAP
SMART-COP [25] CAP SMARTCOP
Simple Triage Scoring System [11] Sepsis STSS
doi:10.1371/journal.pone.0009563.t001
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other chronic care facilities (4%) (Table 2).
The most common presenting symptoms were cough (90%),
fever (68%), shortness of breath (63%) and fatigue (61%). Chest x-
ray evidence consistent with pneumonia was seen on the initial
chest x-ray in 45% of cases (Table 2).
Overall, 16% (n=96) of patients required ICU admission, 9%
(n=55) required mechanical ventilation, and 12% (n=71) died.
The median time (IQR) to ICU admission for patients that
required ICU was 0 days (0 days to 2 days) and the median
duration of ICU stay was 6 days (4 days to 14 days). The median
time (IQR) to mechanical ventilation among those requiring
ventilation was 0 days (0 days to 4 days) and the median duration
of ventilation was 5 days (2 days to 13 days). The median time to
death among fatal cases (IQR) was 13 days (3 days to 25 days).
Performance of Scores for the Prediction of Death
The AUC for the prediction of death ranged from 0.78 to 0.65
(Table 3). The two best predictors of in-hospital mortality were
the PSI (AUC=0.79, 95% CI 0.72–0.83) and the MEDS
(AUC=0.78, 95% CI 0.71 to 0.83). These were the only with
confidence intervals including AUC .0.80 (Table 3). All of the
Table 2. Demographic and clinical characteristics of patients with laboratory confirmed influenza in TIBDN hospitals, 2005–2007.
Total (n=607) Survived (n=536) Died (n=71)
Demographics
Age (years, IQR) 76 (64–83) 76 (62–82) 78 (72–85)
Female 49% (297/607) 49% (264/536) 46% (33/71)
Residence prior to hospitalization
Community 83% (506/607) 85% (453/536) 75% (53/71)
Nursing Home 13% (76/607) 12% (63/536) 18% (13/71)
Other Institutional 4% (25/607) 4% (20/536) 7% (5/71)
Comorbidities and other risk factors for severe influenza
Age.65 74% (451/607) 73% (390/536) 86% (61/71)
Pregnancy 2% (10/607) 2% (10/536) 0% (0/71)
Any comorbid illness 88% (536/607) 87% (468/536) 96% (68/71)
Respiratory (including asthma) 42% (257/607) 42% (226/536) 44% (31/71)
Cardiac (excluding hypertension) 59% (360/607) 58% (309/536) 72% (51/71)
Immunosuppression (including diabetes) 61% (372/607) 60% (323/536) 69% (49/71)
Neuromuscular disorder 8% (47/607) 6% (33/536) 20% (14/71)
Any influenza risk factor 94% (568/607) 93% (493/536) 99% (70/71)
Clinical Features
Fever 85% (517/607) 86% (461/536) 79% (56/71)
Cough 90% (546/607) 91% (487/536) 82% (58/71)
Dyspnea 63% (384/607) 61% (326/536) 82% (58/71)
Fatigue 61% (372/607) 61% (329/536) 61% (43/71)
Temperature .38.0uC 48% (291/607) 50% (266/536) 35% (25/71)
Heart Rate .120 beats/minute 13% (79/607) 13% (67/536) 17% (12/71)
Respiratory Rate .30 breaths/minute 9% (55/607) 9% (46/536) 13% (9/536)
Hypotension (Systolic blood pressure ,90 mmHg) 5% (31/607) 5% (25/536) 8% (6/71)
Laboratory Results and Radiography
White blood cell count (mean, SD) 9.6 (7.6) 9.2 (7.3) 12.6 (8.5)
Platelet count (mean, SD) 216 (90) 214 (88) 224 (106)
Hematocrit (mean, SD) 0.38 (0.06) 0.38 (0.06) 0.37 (0.07)
Sodium (mean, SD) 126 (9) 136 (9) 138 (9)
Creatinine (mean, SD) 122 (111) 119 (107) 146 (136)
Albumin (mean, SD) 32 (7) 33 (7) 29 (7)
AST (mean, SD) 64 (158) 47 (71) 159 (365)
Bilirubin (mean, SD) 17 (46) 17 (49) 16 (19)
Infiltrate on initial Chest X-ray 47% (273/583) 45% (232/514) 59% (41/69)
Treatment
Antiviral Use 40% (245/607) 41% (222/536) 32% (23/71)
*influenza risk factors include age .65, pregnancy, and comorbid conditions including chronic cardiorespiratory illness, immunosuppressive illness and neuromuscular
illness.
doi:10.1371/journal.pone.0009563.t002
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demonstrated statistically significant lack offit(Table3).A graphical
depiction of the correlation between observed and predicted in-
hospital mortality for the top two performing scores is shown in
Figure 1 and 2. When the analysis was repeated using multiple
imputation to replace missing data, the order and magnitude of the
observed AUC values were unchanged [data not shown].
When these scores were used to identify a subset of patients at low
risk of death (,5% risk of death) who could potentially be managed
as outpatients,thesensitivitiesof the scores foridentifying patientsat
risk of in-hospital mortality were good ($85% for all scores) but the
specificity was poor (# 40% for all scores) (Table 4). The sensitivity
and specificity for the PSI score were 93% and 39%. Using the PSI
score to guide admission decisions (i.e. admitting only patients with
a PSI score .87 and an estimated risk of in-hospital mortality of
$5%) would have reduced admissions by 35%. The case fatality
rate in patients with scores of # 87 was 5/231 (2.3%). The
sensitivity and specificity of the MEDS score were 85% and 40%.
Using the MEDS score to guide admission decisions (i.e. admitting
only patients with a MEDS score .5 and an estimated risk of in-
hospitalmortalityof $5%) would have reduced admissionsby 38%.
The case fatality rate in patients with a score # 5 was 11/228
(4.8%).
Performance of Scores in the Prediction of ICU Admission
The AUC for the prediction of ICU admission ranged from
0.73 to 0.58 (Table 5). The best predictor of ICU admission was
SMARTCOP (AUC=0.73, 95% CI 0.67–0.79). No score
demonstrated good performance (AUC$0.80) or included an
AUC=0.80 within the 95% confidence intervals. Furthermore,
SMARTCOP was not well calibrated, and demonstrated a
statistically significant lack of fit (Table 5). A graphical depiction
of the correlation between observed and predicted ICU admission
for SMARTCOP is shown in figure 3. When the analysis was
repeated using multiple imputation to replace missing data, the
order and magnitude of the observed AUC values were
unchanged [data not shown].
When these scores were used to identify a subset of patients at
low risk of requiring ICU care (,5% risk of admission to ICU)
Figure 1. PSI score: observed and predicted mortality in quartile groups. Observed (black) and predicted (grey) in-hospital mortality are
similar within quartiles defined by the PSI score. In the lowest quartile (patients with PSI,80), in-hospital mortality was low (,5%).
doi:10.1371/journal.pone.0009563.g001
Table 3. AUC and Hosmer Lemeshow Goodness of Fit Test
for the prediction of in-hospital mortality.
Score Death* AUC (95% CI)
Hosmer-Lemeshow C statistic
(Chi-Square)*
PSI 0.78 (0.72–0.83) 3.9
MEDS 0.77 (0.71–0.83) 12.6
STSS 0.71 (0.66–0.77) 1.4
SMARTCOP 0.69 (0.62–0.75) 4.3
PMEWS 0.68 (0.61–0.74) 7.4
NHAP 0.68 (0.62–0.74) 10.6*
CURB65 0.66 (0.60–0.72) 4.8
CAP 0.65 (0.58–0.71) 3.3
*p,0.05.
doi:10.1371/journal.pone.0009563.t003
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failed to identify any patients within this low risk category (i.e. the
estimated risk of ICU admission was .5% for all patients). Only
the PSI and SMARTCOP scores identified a subset of patients at
low risk. The sensitivity of both these scores for detecting patients
at risk of ICU admission was 100% (i.e. no patient classified as low
risk required ICU care) but the specificities were both poor (6.0%
for PSI and 2.8% for SMARTCOP) and as a result, neither score
would likely be useful in reducing the number of hospital
admissions (e.g. admitting only patients with a SMARTCOP
score .1 and an estimated risk of ICU admission of $5% would
reduce admissions by only 2.5%) (Table 6).
Re-Examination of Data with Fatal Cases Not Admitted to
ICU Excluded
Because we did not record the ‘do not resuscitate’ status
of patients in our cohort, we conducted a post-hoc analysis
with patients that died outside of the ICU setting excluded as
this group may have included ‘do not resuscitate’ patients that
would otherwise have prognostic features predictive of the
need for ICU admission (e.g. severe hypoxemia) and may
have reduced the ability of scores to predict ICU admission
accurately.
Figure 2. MEDS score: observed and predicted mortality in quartile groups. Observed (black) and predicted (grey) in-hospital mortality are
similar within quartiles defined by the PSI. In the lowest quartile (patients with PSI,80), in-hospital mortality was low (,5%).
doi:10.1371/journal.pone.0009563.g002
Table 4. Sensitivity and Specificity of scores for the
identification of patients at low risk of death (predicted
probability death ,5%).
Score Sensitivity Specificity
Reduction in
Admission
Fatal cases sent home
(false negatives)
PSI 93% 39% 35% 5/213 (2.3%)
MEDS 85% 40% 38% 11/228 (4.8%)
STSS 99% 15% 14% 1/84 (1.1%)
SMARTCOP 100% 2.8% 2.5% 0/15 (0%)
PMEWS 97% 13% 12% 2/74 (2.7%)
CURB65 97% 16% 14% 2/87 (2.2%)
*NHAP and CAP did not classify any patient as having a ,5% risk of death.
doi:10.1371/journal.pone.0009563.t004
Table 5. AUC and Hosmer Lemeshow Goodness of Fit Test
for the prediction of the need for ICU admission.
Score
ICU Admission AUC
(95% CI)
Hosmer-Lemeshow C statistic
(Chi-Square)
SMARTCOP 0.73 (0.67–0.79) 33.0*
MEDS 0.67 (0.61–0.73) 11.7
PSI 0.67 (0.61–0.73) 11.1
CAP 0.65 (0.59–0.71) 0.92
PMEWS 0.63 (0.57–0.69) 12.0
STSS 0.63 (0.57–0.69) 2.1
NHAP 0.62 (0.57–0.68) 3.2
CURB65 0.58 (0.52–0.64) 2.4
*p,0.05.
doi:10.1371/journal.pone.0009563.t005
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we re-analyze our data after excluding patients that died outside of
the ICU, there was little difference in the results, with small
increases in AUC seen for most scores (Tables 7, 8). The only
exception was for SMARTCOP, which demonstrated a substan-
tial improvement in its ability to predict in-hospital death (AUC
0.79, 95% CI 0.73 to 0.86) while remaining the best predictor of
ICU admission (AUC=0.73, 95% CI 0.68 to 0.79).
Discussion
Our study examined the ability of a variety of prognostic scores to
predict outcome (death or ICU admission) in a cohort of patients
admitted to hospital with laboratory confirmed influenza. Unfortu-
nately, we did not identify any prognostic score with either excellent
(AUC.0.90) or good discriminatory ability (i.e. AUC.0.80) for the
prediction of either in-hospital mortality or ICU admission.
The score that best predicted in-hospital mortality was the PSI,
with an AUC of 0.78. The PSI is a pneumonia severity score
developed to assess prognosis in patients with community-acquired
pneumonia. It has subsequently been evaluated for use as a tool to
help standardize the admission decision for patients with CAP and
in one study was demonstrated to reduce the admission of low risk
patients with CAP by 18% without adverse consequences [4,19].
Figure 3. SMARTCOP: observed and predicted ICU admission in quartile groups. Observed (black) and predicted (grey) ICU admission are
similar within quartiles defined by SMARTCOP. In the quartile (patients with SMARTCOP,3), the incidence of ICU admission was low (,5%).
doi:10.1371/journal.pone.0009563.g003
Table 6. Sensitivity and Specificity of scores for the
identification of patients at low risk of ICU admission
(predicted probability ICU admission ,5%).
Score Sensitivity Specificity
Reduction in
Admission
Fatal cases
sent home
PSI 100% 6.0% 5.2% 0/32 (0%)
SMARTCOP 100% 2.8% 2.5% 0/15 (0%)
*MEDS, STSS, PMEWS, CURB65, NHAP and CAP did not classify any patient as
having a ,5% risk of death.
doi:10.1371/journal.pone.0009563.t006
Table 7. Prediction of in-hospital mortality with fatal cases
not admitted to ICU excluded.
Score
Death* AUC
(95% CI)
Hosmer-Lemeshow C statistic
(Chi-Square)*
SMARTCOP 0.79 (0.73–0.85) 5.3
MEDS 0.79 (0.69–0.87) 13.7
PSI 0.76 (0.68–0.84) 9.1
STSS 0.75 (0.67–0.82) 1.1
PMEWS 0.72 (0.62–0.80) 8.0
NHAP 0.71 (0.63–0.79) 16.2*
CURB65 0.67 (0.58–0.75) 1.3
CAP 0.66 (0.57–0.75) 1.8
*p,0.05.
doi:10.1371/journal.pone.0009563.t007
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in-hospital mortality had the potential to reduce admissions by
35%. The main drawback of the PSI is its complexity. The PSI
requires the measurement of 18 variables, including arterial blood
gases, 4 additional laboratory variables, and a chest x-ray.
However, clinicians’ familiarity with this score and its inclusion
in widely endorsed CAP guidelines might partially compensate for
its complexity. An additional concern is that, although the PSI was
a fair predictor of in-hospital mortality, it was a poor predictor of
ICU admission. A score that is a poor predictor of the need for
ICU admission is not an ideal tool on which to base admission
decisions, as patients sent home using such a tool will have a
significant risk of requiring readmission and/or experiencing bad
outcomes at home.
The MEDS score was also a fair predictor of in-hospital
mortality, with an AUC of 0.77 and with 95% confidence intervals
similar to those seen with the PSI but with a lower sensitivity than
the PSI for the identification of patients at risk of in-hospital
mortality (85% vs. 93%). The MEDS score is considerably simpler
than the PSI as it requires the measurement of only 7 variables, of
which only two are laboratory variables (platelet count and
percent bands). The MEDS score also has good face validity for
predicting death in influenza patients, as it includes known risk
factors for complicated influenza such as age.65, nursing home
residence, lower respiratory tract infection, and hypoxemia [20].
In our cohort, the use of the MEDS score in the ER could
potentially reduce admissions by 38%. Unfortunately, the MEDS
score, like the PSI, was also a poor predictor of the need for ICU
admission.
The only score that was a fair predictor of ICU admission was
the SMARTCOP score, with an AUC of 0.73. SMARTCOP was
also 100% sensitive in identifying patients at risk of ICU
admission. However, SMARTCOP had a low specificity (2.8%)
for the identification of at-risk patients and therefore would not
significantly reduce the number of hospital admissions if used as a
triage tool. Furthermore, SMARTCOP was a poor predictor of in-
hospital mortality. SMARTCOP is a relatively simple pneumonia
severity score comprised of only 8 variables, although it does
require arterial blood gases and chest radiography. SMARTCOP
was designed to predict which CAP patients will require invasive
respiratory or vasopressor support and it is not surprising that it
was a better predictor of ICU admission than of in-hospital
mortality. The developers of SMARTCOP have commented that
the PSI and most other pneumonia severity scores place a
considerable emphasis on age and comorbid illnesses as predictors,
as opposed to variables focused more on acute physiologic, and
specifically respiratory, changes. They also note that older age and
severe comorbid illness are predictive of patients being assigned a
‘do not resuscitate’ status; scores that successfully identify patients
that die, without excluding patients designated as ‘do not
resuscitate’ may also overemphasize the importance of these
variables in predicting outcome. When we re-analyze our data
after excluding patients that died outside of the ICU, SMART-
COP became the best predictor of in-hospital mortality while
remaining the best predictor of ICU admission.
The STSS was a fair predictor of in-hospital mortality, with an
AUC of 0.71. The STSS is a sepsis severity score designed to
predict in-hospital mortality and the need for critical care
resources at the time of assessment in the ER. Furthermore, it
was specifically designed as a triage tool for use during influenza
epidemics or pandemics, although it has not been previously
validated in a cohort of patients with influenza. Unlike the PSI and
MEDS, however, the upper 95% confidence interval for the STSS
was ,0.80 and the specificity for identifying patients at risk of in-
hospital mortality was poor at 15%. Thus, our results do not
suggest that the STSS will be useful as a tool to guide admission
decisions for influenza.
All of the other scores examined performed poorly
(AUC,0.70). Of particular note, the other widely used pneumo-
nia severity score, the CURB65 score, was a poor predictor of
both in-hospital mortality and ICU admission. This is an
important finding, as the CURB65 has been suggested for use as
a triage tool for pandemic influenza [7]. PMEWS, another score
proposed for use in an influenza pandemic [7], also performed
poorly in this cohort.
Of note, we initially considered including acute physiology
scores in our analysis (e.g. SOFA, APACHE II, MPMII, etc)
however we did not do so as these scores were designed for use in
the ICU setting, most of these scores included variables that are
only routinely measured in the ICU, and most include levels for
each variable that could only occur in ICU patients. For example,
the SOFA score assigns a value ranging from 0 to 4 for its
‘respiratory’ variable. Scores .1 require that patients be
ventilated. Such scores are unlikely, a priori, to be predictive in
the pre-ICU environment, and when they are predictive it is likely
that they are predicting the obvious (i.e. an intubated patient in the
ER will likely be going to ICU).
Our study has several limitations. Although patients were
enrolled prospectively, data collection was retrospective. However,
the process of data collection was standardized, the variables
included are reasonably objective measures, and there was little
missing data. Our cohort is small compared to those used to derive
most of the prognostic scores we examined; however, our cohort is
large compared to other cohorts of hospitalized patients with
laboratory confirmed influenza, and the large sample sizes used to
derive scores such as PSI are required in part because of the need
to examine large numbers of candidate predictors. Our study was
conducted in a single geographical area and the inclusion of only
patients with laboratory confirmed influenza and these factors may
limit the generalizability of our data to areas with different
approaches to influenza screening. Finally, our study examined
patients with seasonal, and not pandemic, influenza. Extrapolation
to pandemic influenza must be made cautiously. However, a
number of groups have suggested that the CURB65, STSS,
PMEWS and SOFA scores be used for triage during a pandemic
despite the fact that none of these scores has been evaluated in any
population with influenza [3,7–11]. Our results are therefore
important and should be used to determine which scores should
be prioritized for prospective assessment during the current
Table 8. Prediction of ICU admission with fatal cases not
admitted to ICU excluded.
Score
ICU Admission AUC
(95% CI)
Hosmer-Lemeshow C statistic
(Chi-Square)
SMARTCOP 0.74 (0.68–0.79) 33*
MEDS 0.69 (0.63–0.75) 11.0
PSI 0.69 (0.63–0.75) 15.7*
CAP 0.66 (0.60–0.71) 6.9
PMEWS 0.64 (0.58–0.70) 12
STSS 0.64 (0.58–0.71) 2.2
NHAP 0.64 (0.57–0.69) 3.3
CURB65 0.59 (0.53–0.65) 3.0
*p,0.05.
doi:10.1371/journal.pone.0009563.t008
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‘low risk’ for in-patient mortality or ICU admission might have
been at low risk only because of supportive therapy they received
as inpatients. Therefore, these results cannot be interpreted as
predicting outcomes for similar patients in the absence of
hospitalization. However, this is true for all pneumonia severity
scores; nevertheless, the PSI and CURB65, with careful and
ongoing evaluation, have become important management tools for
the triage of patients with CAP [4,6].
In conclusion, our results suggest that currently existent
pneumonia severity scores may not be adequately predictive of
both in-hospital mortality and the need for ICU admission to be
used as decision support tools at the time of initial ER assessment.
There is an urgent need to develop such a tool for pandemic
influenza, given its potential to prevent a significant proportion of
admissions, and to ensure that those patients at risk of severe
outcomes are admitted. In our study, only the PSI and MEDS
score were moderately predictive of in-hospital mortality. These
scores merit further examination for their ability to predict
outcome in both seasonal and pandemic influenza. Interestingly,
the SMARTCOP score was the best predictor of ICU admission,
and the best overall predictor of both outcomes when non-ICU
deaths were excluded from the analysis. SMARTCOP also merits
further examination, particularly in patients with pandemic
influenza, given its relative simplicity and its focus on predicting
ICU admission. Future studies should clearly identify patients
considered that do not wish to have, or are not considered
appropriate for, aggressive care, as these patients should not be
included in analyses designed to predict outcomes and intended
for use as decision support tools (as such patients would never
require ICU care by definition). Our results suggest that the other
prognostic scores examined, including the PMEWS, STSS and
CURB65, are not sufficiently predictive to be useful as admission
tools for seasonal influenza, and raises concern about their use as
outcome predictors for pandemic influenza.
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